Skip to main content

Part of the book series: Milestones in Drug Therapy ((MDT))

Abstract

Despite the extensive research in the field, the precise etiology of bipolar disorder (BD) is not clear; neither, then, is our understanding of the pathogenesis of bipolar depression. What we do know is largely gleaned from investigations of patients with BD irrespective of their mood state. The most consistent neuropathological findings include structural, cellular, and functional changes in cortical and limbic regions, and most explanations for the illness involve pathways that ultimately result in cerebral atrophy and cell loss. Though many theories have been proposed, here, the focus is on the current leading hypotheses of mitochondrial involvement, oxidative stress, the role of inflammation, and neurotrophic factors. Future research is required with a specific focus on the depressive phase of BD in addition to the study of biomarkers to aid clinicians in the diagnosis and targeted treatment of bipolar depression.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Adleman NE, Fromm SJ, Razdan V, Kayser R, Dickstein DP, Brotman MA, Pine DS, Leibenluft E (2012) Cross-sectional and longitudinal abnormalities in brain structure in children with severe mood dysregulation or bipolar disorder. J Child Psychol Psychiatry 53(11):1149–1156

    Article  PubMed  PubMed Central  Google Scholar 

  • Andreazza AC, Cassini C, Rosa AR, Leite MC, de Almeida LMV, Nardin P, Cunha ABN, Cereser KM, Santin A, Gottfried C, Salvador M, Kapczinski F, Goncalves CA (2007a) Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res 41(6):523–529

    Article  PubMed  Google Scholar 

  • Andreazza AC, Noronha Frey B, Erdtmann B, Salvador M, Rombaldi F, Santin A, Goncalves CA, Kapczinski F (2007b) DNA damage in bipolar disorder. Psychiatry Res 153(1):27–32

    Article  CAS  PubMed  Google Scholar 

  • Angst F, Stassen HH, Clayton PJ, Angst J (2002) Mortality of patients with mood disorders: follow-up over 34–38 years. J Affect Dis 68(2–3):167–181

    Article  CAS  PubMed  Google Scholar 

  • Banerjee U, Dasgupta A, Rout JK, Singh OP (2012) Effects of lithium therapy on Na+–K+-ATPase activity and lipid peroxidation in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 37(1):56–61

    Article  CAS  PubMed  Google Scholar 

  • Barbiroli B, Montagna P, Martinelli P, Lodi R, Iotti S, Cortelli P, Funicello R, Zaniol P (1993) Defective brain energy metabolism shown by in vivo 31P MR spectroscopy in 28 patients with mitochondrial cytopathies. J Cereb Blood Flow Metab 13(3):469–474

    Article  CAS  PubMed  Google Scholar 

  • Beech RD, Lowthert L, Leffert JJ, Mason PN, Taylor MM, Umlauf S, Lin A, Lee JY, Maloney K, Muralidharan A, Lorberg B, Zhao H, Newton SS, Mane S, Epperson CN, Sinha R, Blumberg H, Bhagwagar Z (2010) Increased peripheral blood expression of electron transport chain genes in bipolar depression. Bipolar Disord 12(8):813–824

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bengesser SA, Lackner N, Birner A, Fellendorf FT (2015) Peripheral markers of oxidative stress and antioxidative defense in euthymia of bipolar disorder—Gender and obesity effects. J Affect Disord 172:367–374

    Article  CAS  PubMed  Google Scholar 

  • Berk M, Copolov DL, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Bush AI (2008) N-acetyl cysteine for depressive symptoms in bipolar disorder—a double-blind randomized placebo-controlled trial. Biol Psychiatry 64(6):468–475

    Article  CAS  PubMed  Google Scholar 

  • Berk M, Dean O, Cotton SM, Gama CS, Kapczinski F, Fernandes BS, Kohlmann K, Jeavons S, Hewitt K, Allwang C, Cobb H, Bush AI, Schapkaitz I, Dodd S, Malhi GS (2011) The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial. J Affect Disord 135(1–3):389–394

    Article  CAS  PubMed  Google Scholar 

  • Bielau H, Trübner K, Krell D, Agelink MW, Bernstein HG, Stauch R, Mawrin C, Danos P, Gerhard L, Bogerts B, Baumann B (2005) Volume deficits of subcortical nuclei in mood disorders. Eur Arch Psychiatry Clin Neurosci 255(6):401–412

    Article  PubMed  Google Scholar 

  • Birkenaes AB, Opjordsmoen S, Brunborg C, Engh JA, Jonsdottir H, Ringen PA, Simonsen C, Vaskinn A, Birkeland KI, Friis S, Sundet K, Andreassen OA (2007) The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. J Clin Psychiatry 68(6):917–923

    Article  PubMed  Google Scholar 

  • Boufidou F, Nikolaou C, Alevizos B, Liappas IA, Christodoulou GN (2004) Cytokine production in bipolar affective disorder patients under lithium treatment. J Affect Disord 82(2):309–313

    Article  CAS  PubMed  Google Scholar 

  • Buttner N, Bhattacharyya S, Walsh J, Benes FM (2007) DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia. Schizophr Res 93(1–3):33–41

    Article  PubMed  PubMed Central  Google Scholar 

  • Byne W, Tatusov A, Yiannoulos G, Vong GS, Marcus S (2008) Effects of mental illness and aging in two thalamic nuclei. Schizophr Res 106(2–3):172–181

    Article  PubMed  PubMed Central  Google Scholar 

  • Campbell S, Macqueen G (2004) The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci 29(6):417–426

    PubMed  PubMed Central  Google Scholar 

  • Can M, Güven B, Atik L, Konuk N (2011) Lipid peroxidation and serum antioxidant enzymes activity in patients with bipolar and major depressive disorders. J Mood Disord 1(1):14

    Google Scholar 

  • Cataldo AM, McPhie DL, Lange NT, Punzell S, Elmiligy S, Ye NZ, Froimowitz MP, Hassinger LC, Menesale EB, Sargent LW, Logan DJ, Carpenter AE, Cohen BM (2010) Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. Am J Pathol 177(2):575–585

    Article  PubMed  PubMed Central  Google Scholar 

  • Chaturvedi RK, Flint Beal M (2013) Mitochondrial diseases of the brain. Free Radic Biol Med 63:1–29

    Article  CAS  PubMed  Google Scholar 

  • Chepenik LG, Fredericks C, Papademetris X, Spencer L, Lacadie C, Wang F, Pittman B, Duncan JS, Staib LH, Duman RS, Gelernter J, Blumberg HP (2009) Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder. Neuropsychopharmacology 34(4):944–951

    Article  CAS  PubMed  Google Scholar 

  • Cunha ÂB, Andreazza AC, Gomes FA, Frey BN, Silveira LE, Gonçalves CA, Kapczinski F (2008) Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 258(5):300–304

    Article  PubMed  Google Scholar 

  • D’Addario C, Dell’Osso B, Palazzo MC, Benatti B, Lietti L, Cattaneo E, Galimberti D, Fenoglio C, Cortini F, Scarpini E, Arosio B, Di Francesco A, Di Benedetto M, Romualdi P, Candeletti S, Mari D, Bergamaschini L, Bresolin N, Maccarrone M, Altamura AC (2012) Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDII. Neuropsychopharmacology 37(7):1647–1655

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Dargel AA, Godin O, Kapczinski F, Kupfer DJ, Leboyer M (2015) C-reactive protein alterations in bipolar disorder: a meta-analysis. J Clin Psychiatry 76(2):142–150

    Article  PubMed  Google Scholar 

  • De Berardis D, Conti CM, Campanella D, Carano A, Scali M, Valchera A, Serroni N, Pizzorno AM, D’Albenzio A, Fulcheri M, Gambi F, La Rovere R, Cotellessa C, Salerno RM, Ferro FM (2008) Evaluation of C-reactive protein and total serum cholesterol in adult patients with bipolar disorder. Int J Immunopathol Pharmacol 21(2):319–324

    Article  PubMed  Google Scholar 

  • de Oliveira GS, Ceresér KM, Fernandes BS, Kauer-Sant’Anna M, Fries GR, Stertz L, Aguiar B, Pfaffenseller B, Kapczinski F (2009) Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. J Psychiatr Res 43(14):1171–1174

    Article  PubMed  Google Scholar 

  • Dell’Osso B, D’Addario C, Carlotta Palazzo M, Benatti B, Camuri G, Galimberti D, Fenoglio C, Scarpini E, Di Francesco A, Maccarrone M, Altamura AC (2014) Epigenetic modulation of BDNF gene: differences in DNA methylation between unipolar and bipolar patients. J Affect Disord 166:330–333

    Article  PubMed  CAS  Google Scholar 

  • Dickerson F, Stallings C, Origoni A, Boronow J, Yolken R (2007) Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 31(4):952–955

    Article  CAS  PubMed  Google Scholar 

  • Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Yolken R (2013) Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder. J Affect Disord 150(2):456–459

    Article  CAS  PubMed  Google Scholar 

  • Dwivedi T, Zhang H (2015) Lithium-induced neuroprotection is associated with epigenetic modification of specific BDNF gene promoter and altered expression of apoptotic-regulatory proteins. Front Neurosci 8:457

    Article  PubMed  PubMed Central  Google Scholar 

  • Eleff SM, Barker PB, Blackband SJ, Chatham JC, Lutz NW, Johns DR, Bryan RN, Hurko O (1990) Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine. Ann Neurol 27(6):626–630

    Article  CAS  PubMed  Google Scholar 

  • ElvsÃ¥shagen T, Vera E, Bøen E, Bratlie J, Andreassen OA, Josefsen D, Malt UF, Blasco MA, Boye B (2011) The load of short telomeres is increased and associated with lifetime number of depressive episodes in bipolar II disorder. J Affect Disord 135(1–3):43–50

    Article  PubMed  Google Scholar 

  • Fernandes BS, Gama CS, Kauer-Sant’Anna M, Lobato MI, Belmonte-de-Abreu P, Kapczinski F (2009) Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis. J Psychiatr Res 43(15):1200–1204

    Article  PubMed  Google Scholar 

  • Fernandes BS, Gama CS, Maria Ceresér K, Yatham LN, Fries GR, Colpo G, de Lucena D, Kunz M, Gomes FA, Kapczinski F (2011) Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res 45(8):995–1004

    Article  PubMed  Google Scholar 

  • Foland-Ross LC, Brooks JO, Mintz J, Bartzokis G, Townsend J, Thompson PM, Altshuler LL (2012) Mood-state effects on amygdala volume in bipolar disorder. J Affect Disord 139(3):298–301

    Article  PubMed  PubMed Central  Google Scholar 

  • Gawryluk JW, Wang J-F, Andreazza AC, Shao L, Young LT (2011) Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol 14(1):123–130

    Article  CAS  PubMed  Google Scholar 

  • Ghaznavi S, Deckersbach T (2012) Rumination in bipolar disorder: evidence for an unquiet mind. Biol Mood Anxiety Disord 2(1):2

    Article  PubMed  PubMed Central  Google Scholar 

  • Gigante AD, Young LT, Yatham LN, Andreazza AC, Nery FG, Grinberg LT, Heinsen H, Lafer B (2011) Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis. Int J Neuropsychopharmacol 14(8):1075–1089

    Article  CAS  PubMed  Google Scholar 

  • Goldstein B, Young LT (2013) Toward clinically applicable biomarkers in bipolar disorder: focus on BDNF, inflammatory markers, and endothelial function. Curr Psychiatry Rep 15(12):1–7

    Article  Google Scholar 

  • Goldstein BI, Collinger KA, Lotrich F, Marsland AL, Gill M-K, Axelson DA, Birmaher B (2011) Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders. J Child Adolesc Psychopharmacol 21(5):479–484

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hartberg CB, Jørgensen KN, Haukvik UK, Westlye LT, Melle I, Andreassen OA, Agartz I (2015) Lithium treatment and hippocampal subfields and amygdala volumes in bipolar disorder. Bipolar Disord 17(5):496–506

    Article  CAS  PubMed  Google Scholar 

  • Hashimoto K (2010) Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future direction. Psychiatry Clin Neurosci 64(4):341–357

    Article  CAS  PubMed  Google Scholar 

  • Himmerich H, Bartsch S, Hamer H, Mergl R, Schonherr J, Petersein C, Munzer A, Kirkby KC, Bauer K, Sack U (2014) Modulation of cytokine production by drugs with antiepileptic or mood stabilizer properties in anti-CD3- and anti-Cd40-stimulated blood in vitro. Oxid Med Cell Longev 2014:806162

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hirayasu Y, Shenton ME, Salisbury DF, Kwon JS et al (1999) Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry 156(7):1091–1093

    CAS  PubMed  PubMed Central  Google Scholar 

  • Huzayyin AA, Andreazza AC, Turecki G, Cruceanu C, Rouleau GA, Alda M, Young LT (2014) Decreased global methylation in patients with bipolar disorder who respond to lithium. Int J Neuropsychopharmacol 17(4):561–569

    Article  CAS  PubMed  Google Scholar 

  • Inal-Emiroglu FN, Karabay N, Resmi H, Guleryuz H (2015) Correlations between amygdala volumes and serum levels of BDNF and NGF as a neurobiological marker in adolescents with bipolar disorder. J Affect Disord 182:50–56

    Article  CAS  PubMed  Google Scholar 

  • Janak PH, Tye KM (2015) From circuits to behaviour in the amygdala. Nature 517(7534):284–292

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kapczinski F, Frey BN, Andreazza AC, Kauer-Sant’Anna M, Cunha AB, Post RM (2008) Increased oxidative stress as a mechanism for decreased BDNF levels in acute manic episodes. Rev Bras Psiquiatr 30(3):243–245

    Article  PubMed  Google Scholar 

  • Kapczinski F, Dias VV, Kauer-Sant’Anna M, Frey BN, Grassi-Oliveira R, Colom F, Berk M (2009) Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother 9(7):957–966

    Article  PubMed  Google Scholar 

  • Kapczinski F, Dal-Pizzol F, Teixeira AL, Magalhaes PVS, Kauer-Sant’Anna M, Klamt F, Moreira JCF, Augusto de Bittencourt Pasquali M, Fries GR, Quevedo J, Gama CS, Post R (2011) Peripheral biomarkers and illness activity in bipolar disorder. J Psychiatr Res 45(2):156–161

    Article  PubMed  Google Scholar 

  • Kapczinski F, Magalhães PVS, Balanzá-Martinez V, Dias VV, Frangou S, Gama CS, Gonzalez-Pinto A, Grande I, Ha K, Kauer-Sant’Anna M, Kunz M, Kupka R, Leboyer M, Lopez-Jaramillo C, Post RM, Rybakowski JK, Scott J, Strejilevitch S, Tohen M, Vazquez G, Yatham L, Vieta E, Berk M (2014) Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force Report. Acta Psychiatr Scand 130(5):354–363

    Article  CAS  PubMed  Google Scholar 

  • Kato T (2007) Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications. CNS Drugs 21(1):1–11

    Article  CAS  PubMed  Google Scholar 

  • Kato T, Takahashi S, Shioiri T, Inubushi T (1992) Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy. J Affect Disord 26(4):223–230

    Article  CAS  PubMed  Google Scholar 

  • Kato T, Takahashi S, Shioiri T, Murashita J, Hamakawa H, Inubushi T (1994) Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. J Affect Disord 31(2):125–133

    Article  CAS  PubMed  Google Scholar 

  • Kato T, Shioiri T, Murashita J, Hamakawa H, Takahashi Y, Inubushi T, Takahashi S (1995) Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS. Psychol Med 25(03):557–566

    Article  CAS  PubMed  Google Scholar 

  • Kim H-W, Rapoport SI, Rao JS (2010) Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients. Neurobiol Dis 37(3):596–603

    Article  CAS  PubMed  Google Scholar 

  • Kittel-Schneider S, Wobrock T, Scherk H, Schneider-Axmann T, Trost S, Zilles D, Wolf C, Schmitt A, Malchow B, Hasan A, Backens M, Reith W, Falkai P, Gruber O, Reif A (2015) Influence of DGKH variants on amygdala volume in patients with bipolar affective disorder and schizophrenia. Eur Arch Psychiatry Clin Neurosci 265(2):127–136

    Article  CAS  PubMed  Google Scholar 

  • Knijff EM, Nadine Breunis M, Kupka RW, de Wit HJ, Ruwhof C, Akkerhuis GW, Nolen WA, Drexhage HA (2007) An imbalance in the production of IL-1ß and IL-6 by monocytes of bipolar patients: restoration by lithium treatment. Bipolar Disord 9(7):743–753

    Article  CAS  PubMed  Google Scholar 

  • Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan AE, Cinkilinc N (2002) Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct 20(2):171–175

    Article  CAS  PubMed  Google Scholar 

  • Kunz M, Gama CS, Andreazza AC, Salvador M, Ceresér KM, Gomes FA, Belmonte-de-Abreu PS, Berk M, Kapczinski F (2008) Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 32(7):1677–1681

    Article  CAS  PubMed  Google Scholar 

  • Lee B-H, Kim Y-K (2012) Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders. J Affect Disord 136(1–2):181–184

    Article  CAS  PubMed  Google Scholar 

  • Lima IMM, Barros A, Rosa DV, Albuquerque M (2015) Analysis of telomere attrition in bipolar disorder. J Affect Disord 172:43–47

    Article  CAS  PubMed  Google Scholar 

  • Lindqvist D, Epel ES, Mellon SH, Penninx BW, Révész D, Verhoeven JE, Reus VI, Lin J, Mahan L, Hough CM, Rosser R, Saverio Bersani F, Blackburn EH, Wolkowitz OM (2015) Psychiatric disorders and leukocyte telomere length: underlying mechanisms linking mental illness with cellular aging. Neurosci Biobehav Rev 55:333–364

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liu L, Schulz SC, Lee S, Reutiman TJ, Fatemi SH (2007) Hippocampal CA1 pyramidal cell size is reduced in bipolar disorder. Cell Mol Neurobiol 27(3):351–358

    Article  PubMed  Google Scholar 

  • Loch AA, Zanetti MV, de Sousa RT, Chaim TM, Serpa MH, Gattaz WF, Teixeira AL, Machado-Vieira R (2015) Elevated neurotrophin-3 and neurotrophin 4/5 levels in unmedicated bipolar depression and the effects of lithium. Prog Neuropsychopharmacol Biol Psychiatry 56:243–246

    Article  CAS  PubMed  Google Scholar 

  • López-Armada MJ, Riveiro-Naveira RR, Vaamonde-García C, Valcárcel-Ares MN (2013) Mitochondrial dysfunction and the inflammatory response. Mitochondrion 13:106–118

    Article  PubMed  CAS  Google Scholar 

  • MacDonald ML, Naydenov A, Chu M, Matzilevich D, Konradi C (2006) Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder. Bipolar Disord 8(3):255–264

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Machado-Vieira R, Dietrich MO, Leke R, Cereser VH, Zanatto V, Kapczinski F, Souza DO, Portela LV, Gentil V (2007) Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biol Psychiatry 61(2):142–144

    Article  CAS  PubMed  Google Scholar 

  • Magalhães PV, Dean OM, Bush AI, Copolov DL, Malhi GS, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Berk M (2011) N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial. J Affect Disord 129(1–3):317–320

    Article  PubMed  CAS  Google Scholar 

  • Matsuo K, Walss-bass C, Nery FG, Nicoletti MA, Hatch JP, Frey BN, Monkul ES, Zunta-soares GB, Bowden CL, Escamilla MA, Soares JC (2009) Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder. Neuropsychopharmacology 34(8):1904–1913

    Article  CAS  PubMed  Google Scholar 

  • Modabbernia A, Taslimi S, Brietzke E, Ashrafi M (2013) Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol Psychiatry 74(1):15–25

    Article  CAS  PubMed  Google Scholar 

  • Moniczewski A, Gawlik M, Smaga I, Niedzielska E, Krzek J, PrzegaliÅ„ski E, Pera J, Filip M (2015) Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 1. Chemical aspects and biological sources of oxidative stress in the brain. Pharmacol Rep 67(3):560–568

    Article  CAS  PubMed  Google Scholar 

  • Moore CM, Christensen JD, Lafer B, Fava M et al (1997) Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study. Am J Psychiatry 154(1):116–118

    Article  CAS  PubMed  Google Scholar 

  • Moore GJ, Cortese BM, Glitz DA, Zajac-Benitez C, Quiroz JA, Uhde TW, Drevets WC, Manji HK (2009) A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. J Clin Psychiatry 70(5):699–705

    Article  CAS  PubMed  Google Scholar 

  • Morawetz C, Bode S, Baudewig J, Kirilina E, Heekeren HR (2016) Changes in effective connectivity between dorsal and ventral prefrontal regions moderate emotion regulation. Cereb Cortex 26(5):1923–1937

    Article  PubMed  Google Scholar 

  • Müller N, Schwarz MJ (2007) The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry 12(11):988–1000

    Article  PubMed  CAS  Google Scholar 

  • Munkholm K, Braüner JV, Kessing LV, Vinberg M (2013) Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. J Psychiatr Res 47(9):1119–1133

    Article  PubMed  Google Scholar 

  • Munkholm K, Poulsen HE, Kessing LV, Vinberg M (2015) Elevated levels of urinary markers of oxidatively generated DNA and RNA damage in bipolar disorder. Bipolar Disord 17(3):257–268

    Article  CAS  PubMed  Google Scholar 

  • Naydenov AV, MacDonald ML, Ongur D, Konradi C (2007) Differences in lymphocyte electron transport gene expression levels between subjects with bipolar disorder and normal controls in response to glucose deprivation stress. Arch Gen Psychiatry 64(5):555–564

    Article  PubMed  Google Scholar 

  • Nugent AC, Diazgranados N, Carlson PJ, Ibrahim L, Luckenbaugh DA, Brutsche N, Herscovitch P, Drevets WC, Zarate CA (2014) Neural correlates of rapid antidepressant response to ketamine in bipolar disorder. Bipolar Disord 16(2):119–128

    Article  CAS  PubMed  Google Scholar 

  • Ortiz-Domínguez A, Hernández ME, Berlanga C, Gutiérrez-Mora D, Moreno J, Heinze G, Pavón L (2007) Immune variations in bipolar disorder: phasic differences. Bipolar Disord 9(6):596–602

    Article  PubMed  Google Scholar 

  • Otsuki K, Uchida S, Watanuki T, Wakabayashi Y, Fujimoto M, Matsubara T, Funato H, Watanabe Y (2008) Altered expression of neurotrophic factors in patients with major depression. J Psychiatr Res 42(14):1145–1153

    Article  PubMed  Google Scholar 

  • Palmier-Claus JE, Dodd A, Tai S, Emsley R, Mansell W (2015) Appraisals to affect: testing the integrative cognitive model of bipolar disorder. Br J Clin Psychol 2015

    Google Scholar 

  • Petersein C, Sack U, Mergl R, Schonherr J, Schmidt F, Lichtblau N, Kirkby K, Bauer K, Himmerich H (2015) Impact of lithium alone and in combination with antidepressants on cytokine production in vitro. J Neural Transm 122(1):109–122

    Article  CAS  PubMed  Google Scholar 

  • Post RM (1992) Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 149(8):999–1010

    Article  CAS  PubMed  Google Scholar 

  • Radaelli D, Sferrazza Papa G, Vai B, Poletti S, Smeraldi E, Colombo C, Benedetti F (2015) Fronto-limbic disconnection in bipolar disorder. Eur Psychiatry 30(1):82–88

    Article  CAS  PubMed  Google Scholar 

  • Rao JS, Harry GJ, Rapoport SI, Kim HW (2010) Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry 15(4):384–392

    Article  CAS  PubMed  Google Scholar 

  • Regenold WT, Phatak P, Marano CM, Sassan A, Conley RR, Kling MA (2009) Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis. Biol Psychiatry 65(6):489–494

    Article  CAS  PubMed  Google Scholar 

  • Rosa AR, Frey BN, Andreazza AC, Cereser KM, Cunha ABM, Quevedo J, Santin A, Gottfried C, Goncalves CA, Vieta E, Kapczinski F (2006) Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neurosci Lett 407(2):146–150

    Article  CAS  PubMed  Google Scholar 

  • Rubinsztein JS, Michael A, Underwood BR, Tempest M, Sahakian BJ (2006) Impaired cognition and decision-making in bipolar depression but no ‘affective bias’ evident. Psychol Med 36(5):629–639

    Article  CAS  PubMed  Google Scholar 

  • Rybakowski JK, Permoda-Osip A, Skibinska M, Adamski R, Bartkowska-Sniatkowska A (2013) Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved? Hum Psychopharmacol 28(1):87–90

    Article  CAS  PubMed  Google Scholar 

  • Salzman CD, Fusi S (2010) Emotion, cognition, and mental state representation in amygdala and prefrontal cortex. Ann Rev Neurosci 33:173–202

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Scola G, Andreazza AC (2015) The role of neurotrophins in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 56:122–128

    Article  CAS  PubMed  Google Scholar 

  • Selek S, Savas HA, Gergerlioglu HS, Bulbul F, Uz E, Yumru M (2008) The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. J Affect Disord 107(1–3):89–94

    Article  CAS  PubMed  Google Scholar 

  • Shibata T, Yamagata H, Uchida S, Otsuki K, Hobara T, Higuchi F, Abe N, Watanabe Y (2013) The alteration of hypoxia inducible factor-1 (HIF-1) and its target genes in mood disorder patients. Prog Neuropsychopharmacol Biol Psychiatry 43:222–229

    Article  CAS  PubMed  Google Scholar 

  • Singh MK, Chang KD, Kelley RG, Saggar M, Reiss AL, Gotlib IH (2014) Early signs of anomalous neural functional connectivity in healthy offspring of parents with bipolar disorder. Bipolar Disord 16(7):678–689

    Article  PubMed  PubMed Central  Google Scholar 

  • Soczynska JK, Kennedy SH, Chow CSM, Woldeyohannes HO, Konarski JZ, McIntyre RS (2008) Acetyl-L-carnitine and a-lipoic acid: possible neurotherapeutic agents for mood disorders? Expert Opin Investig Drugs 17(6):827–843

    Article  CAS  PubMed  Google Scholar 

  • Soeiro-de-Souza MG, Andreazza AC, Carvalho AF, Machado-Vieira R, Young LT, Moreno RA (2013) Number of manic episodes is associated with elevated DNA oxidation in bipolar I disorder. Int J Neuropsychopharmacol 16(7):1505–1512

    Article  CAS  PubMed  Google Scholar 

  • Stork C, Renshaw PF (2005) Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry 10(10):900–919

    Article  CAS  PubMed  Google Scholar 

  • Su SC, Sun MT, Wen MJ, Lin CJ, Chen YC, Hung YJ (2011) Brain-derived neurotrophic factor, adiponectin, and proinflammatory markers in various subtypes of depression in young men. Int J Psychiatry Med 42(3):211–226

    Article  PubMed  Google Scholar 

  • Sun X, Jun-Feng W, Tseng M, Young LT (2006) Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. J Psychiatr Neurosci 31(3):189–196

    Google Scholar 

  • Takebayashi M, Hisaoka K, Nishida A, Tsuchioka M, Miyoshi I, Kozuru T, Hikasa S, Okamoto Y, Shinno H, Morinobu S, Yamawaki S (2006) Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders. Int J Neuropsychopharmacol 9(5):607–612

    Article  CAS  PubMed  Google Scholar 

  • Tang V, Wang J-F (2013) Oxidative stress in bipolar disorder. Biochem Anal Biochem 2(2):1–8

    Article  Google Scholar 

  • Taylor MA, Abrams R (1987) Cognitive impairment patterns in schizophrenia and affective disorder. J Neurol Neurosurg Psychiatry 50(7):895–899

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tunca Z, Kivircik Akdede B, Özerdem A, Alkin T, Polat S, Ceylan D, Bayin M, Cengizçetin Kocuk N, Simsek S, Resmi H, Akan P (2015) Diverse glial cell line-derived neurotrophic factor (GDNF) support between mania and schizophrenia: a comparative study in four major psychiatric disorders. Eur Psychiatry 30(2):198–204

    Article  CAS  PubMed  Google Scholar 

  • Uranova N, Orlovskaya D, Vikhreva O, Zimina I, Kolomeets N, Vostrikov V, Rachmanova V (2001) Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull 55(5):597–610

    Article  CAS  PubMed  Google Scholar 

  • Versace A, Andreazza AC, Young LT, Fournier JC, Almeida JR, Stiffler RS, Lockovich JC, Aslam HA, Pollock MH, Park H, Nimgaonkar VL, Kupfer DJ, Phillips ML (2014) Elevated serum measures of lipid peroxidation and abnormal prefrontal white matter in euthymic bipolar adults: toward peripheral biomarkers of bipolar disorder. Mol Psychiatry 19(2):200–208

    Article  CAS  PubMed  Google Scholar 

  • Wake H, Moorhouse AJ, Miyamoto A, Nabekura J (2013) Microglia: actively surveying and shaping neuronal circuit structure and function. Trends Neurosci 36(4):209–217

    Article  CAS  PubMed  Google Scholar 

  • Walz JC, Andreazza AC, Frey BN, Cacilhas AA, Cereser KMM, Cunha ABM, Weyne F, Stertz L, Santin A, Goncalves CA, Kapczinski F (2007) Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder. Neurosci Lett 415(1):87–89

    Article  CAS  PubMed  Google Scholar 

  • Wang JF (2007) Defects of mitochondrial electron transport chain in bipolar disorder: implications for mood-stabilizing treatment. Can J Psychiatry 52(12):753–762

    PubMed  Google Scholar 

  • Wang JF, Young LT (2009) Understanding the neurobiology of bipolar depression. In: Zarate CA, Manji HK (eds) Bipolar depression: molecular neurobiology, clinical diagnosis and pharmacotherapy. Milestones in drug therapy. Birkhäuser Verlag, Basel, pp 77–94

    Chapter  Google Scholar 

  • Wang JF, Shao L, Sun X, Young LT (2009) Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord 11(5):523–529

    Article  CAS  PubMed  Google Scholar 

  • Washizuka S, Kakiuchi C, Mori K, Tajima O, Akiyama T, Kato T (2005) Expression of mitochondria-related genes in lymphoblastoid cells from patients with bipolar disorder. Bipolar Disord 7(2):146–152

    Article  CAS  PubMed  Google Scholar 

  • Yasuda S, Liang MH, Marinova Z, Yahyavi A, Chuang DM (2009) The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol Psychiatry 14(1):51–59

    Article  CAS  PubMed  Google Scholar 

  • Zhang X, Zhang Z, Sha W, Xie C, Xi G, Zhou H, Zhang Y (2010) Effect of treatment on serum glial cell line-derived neurotrophic factor in bipolar patients. J Affect Disord 126(1–2):326–329

    Article  CAS  PubMed  Google Scholar 

  • Zhou R, Yazdi AS, Menu P, Tschopp J (2011) A role for mitochondria in NLRP3 inflammasome activation. Nature 469(7329):221–225

    Article  CAS  PubMed  Google Scholar 

  • Zunszain PA, Anacker C, Cattaneo A, Carvalho LA, Pariante CM (2011) Glucocorticoids, cytokines and brain abnormalities in depression. Prog Neuropsychopharmacol Biol Psychiatry 35(3):722–729

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L. Trevor Young MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland (outside the USA)

About this chapter

Cite this chapter

Chintoh, A.F., Young, L.T. (2016). Understanding the Neurobiology of Bipolar Depression. In: Zarate Jr., C., Manji, H. (eds) Bipolar Depression: Molecular Neurobiology, Clinical Diagnosis, and Pharmacotherapy. Milestones in Drug Therapy. Springer, Cham. https://doi.org/10.1007/978-3-319-31689-5_6

Download citation

Publish with us

Policies and ethics